A 15-Year-Old Who Changed Cancer Detection Forever!
At just 15 years old, Jack Andraka revolutionized cancer detection with a low-cost, ultra-sensitive paper sensor for
early-stage pancreatic cancer. His invention is faster, more accurate, and affordable compared to traditional methods, making early diagnosis possible for millions. Despite facing rejections, his determination and scientific brilliance earned him the Gordon E. Moore Award in 2012. His breakthrough could transform global healthcare, proving that age is no barrier to innovation!
by R Ni · 2024 · Cited by 3 — This approach focuses on early detection and progression monitoring of pancreatic cancer. Utilizing tumor-targeted Ag nanoparticles and tapered ...
by J Liang · 2023 — Potential applications include sensitive and rapid detection of CA 19-9 for early diagnosis of pancreatic cancer using just a few drops of ...
by TV Huynh · 2024 · Cited by 5 — The SPE||EGM/Ab immunosensor is a promising electrochemical biosensing probe for detecting CA19-9 in human serum and saliva for clinical diagnosis and ...
24 Feb 2023 — This purpose of this research was to develop a non-invasive, fast, and highly sensitive early diagnostic method for pancreatic cancer through ...
by A Dukle · 2022 · Cited by 18 — The paper-based sensor used for screening must be fast, accurate, reliable, and must have a low limit of detection. A low limit of detection ...
by NH Stoecklein · 2023 · Cited by 22 — This study sought to amplify assay-sensitivity by employing diagnostic leukapheresis (DLA) to screen large blood volumes.
by T Yin · 2023 · Cited by 45 — We demonstrate an accurate and robust portable GFET array biosensor platform for the detection of pancreatic ductal adenocarcinoma (PDAC) in patients' plasma.
by M Kawai · 2024 · Cited by 3 — We demonstrate that the 100 highly expressed miRNAs and their combination with CA19-9 could be biomarkers for the specific and early detection of pancreatic ...
by J von Burstin · 2008 · Cited by 101 — We have investigated novel molecular near-infrared fluorescent (NIRF) in vivo imaging techniques in clinically relevant mouse models of pancreatic cancer.
by CJ Yang · 2020 · Cited by 20 — We are able to contribute to highly sensitive detection of very low concentration of the biomarkers representing the earliest stage pancreatic ...
Ads
SponsoredNGS is transforming CDx, combining broad insights with qPCR’s rapid turnaround. Uniting qPCR’s speed with NGS’s insights for precision liquid biopsy. Over 43 Year History.
This advanced Raman system allows for detailed molecular spectroscopic examination of individual cells, offering more practical information and enabling earlier detection and accurate staging of pancreatic cancer compared to conventional multicellular Raman spectroscopy
Transcriptomic analysis using high-throughput gene screening and transcriptomic databases confirmed the ability and accuracy of this method to identify molecular changes in normal, early, and metastatic pancreatic cancer cells. Key findings revealed that cell adhesion, migration, and the extracellular matrix are closely related to single-cell Raman spectroscopy (SCRS) results, highlighting components such as collagen, phospholipids, and carotene. Therefore, the SCRS approach provides a comprehensive view of the molecular composition, biological function, and material changes in cells, offering a novel, accurate, reliable, rapid, and efficient method for diagnosing and monitoring pancreatic cancer.
,